2024 Q4 Form 10-Q Financial Statement

#000149315224049310 Filed on December 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue $32.73K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $32.73K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit 0.0%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $24.52K
YoY Change 127.78%
Operating Profit $8.208K
YoY Change -176.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $8.208K
YoY Change -176.25%
Income Tax
% Of Pretax Income
Net Earnings $8.208K
YoY Change -176.25%
Net Earnings / Revenue 25.08%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 177.1M shares
Diluted Shares Outstanding 177.1M shares

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.719K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.719K
YoY Change -78.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.719K
Total Long-Term Assets $0.00
Total Assets $1.719K
YoY Change -78.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $104.4K
YoY Change -19.65%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $104.4K
Total Long-Term Liabilities
Total Liabilities $104.4K
YoY Change -19.65%
SHAREHOLDERS EQUITY
Retained Earnings -$1.075M
YoY Change -1.75%
Common Stock $139.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$102.6K
YoY Change
Total Liabilities & Shareholders Equity $1.719K
YoY Change -78.73%

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income $8.208K
YoY Change -176.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Operating Expenses
OperatingExpenses
21581 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
24518 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2033 usd
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
1719 usd
CY2024Q4 us-gaap Assets
Assets
1719 usd
CY2024Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13200 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
104354 usd
CY2024Q4 GFMH Common Stock To Be Issued
CommonStockToBeIssued
381532 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-102635 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1719 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Entity Central Index Key
EntityCentralIndexKey
0000820771
CY2024Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-18945
dei Entity Registrant Name
EntityRegistrantName
GOLIATH FILM AND MEDIA HOLDINGS
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1055077
dei Entity Address Address Line1
EntityAddressAddressLine1
112 N. Curry Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Carson City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89703
dei City Area Code
CityAreaCode
(310)
dei Local Phone Number
LocalPhoneNumber
467-0721
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
dei Trading Symbol
TradingSymbol
GFMH
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
138964917 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q4 us-gaap Cash
Cash
1719 usd
CY2024Q2 us-gaap Cash
Cash
437 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
437 usd
CY2024Q2 us-gaap Assets
Assets
437 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14685 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
101039 usd
CY2024Q4 us-gaap Liabilities
Liabilities
104354 usd
CY2024Q2 us-gaap Liabilities
Liabilities
101039 usd
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
199000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
199000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138964917 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138964917 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
138966 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
138966 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
451500 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
451500 usd
CY2024Q2 GFMH Common Stock To Be Issued
CommonStockToBeIssued
381532 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1074633 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1072600 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-100602 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
437 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32726 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32726 usd
us-gaap Gross Profit
GrossProfit
32726 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
32726 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34759 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21581 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24518 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10764 usd
us-gaap Operating Expenses
OperatingExpenses
34759 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
10764 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21581 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
8208 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10764 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2033 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21581 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8208 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10764 usd
us-gaap Net Income Loss
NetIncomeLoss
-2033 usd
us-gaap Net Income Loss
NetIncomeLoss
-21581 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
8208 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10764 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177118116 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177118116 shares
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-110843 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
8208 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-102635 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-100602 usd
us-gaap Net Income Loss
NetIncomeLoss
-2033 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-102635 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-111023 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10764 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-121787 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-100206 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-100206 usd
us-gaap Net Income Loss
NetIncomeLoss
-21581 usd
us-gaap Net Income Loss
NetIncomeLoss
-21581 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-121787 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-121787 usd
us-gaap Net Income Loss
NetIncomeLoss
-2033 usd
us-gaap Net Income Loss
NetIncomeLoss
-21581 usd
GFMH Expenses Paid On Behalf Of Company Related Party
ExpensesPaidOnBehalfOfCompanyRelatedParty
23340 usd
GFMH Expenses Paid On Behalf Of Company Related Party
ExpensesPaidOnBehalfOfCompanyRelatedParty
14045 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1485 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-86 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-26735 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-8010 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6913 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15632 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8195 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8195 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1282 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8632 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
437 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9214 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1719 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
582 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-02-16
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zq7OYffGangj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zuJGEQeH0pn5">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on the Company’s financial condition and results of operations during the period in which such changes occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual results could differ from those estimates. The Company’s financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q4 us-gaap Theatrical Film Costs Production
TheatricalFilmCostsProduction
0 usd
CY2023Q4 us-gaap Theatrical Film Costs Production
TheatricalFilmCostsProduction
0 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32726 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32726 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2024Q4 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2023Q4 us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zOxqT2YEb095" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zZGldmW4hRNd">Concentrations, Risks, and Uncertainties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s working capital financing has come from revenues and related parties during three and six months ended October 31, 2024. The Company’s working capital financing has entirely come from related parties during three and six months ended October 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
199000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
199000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
CY2024Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
38153269 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138964917 shares
us-gaap Substantial Doubt About Going Concern Conditions Or Events
SubstantialDoubtAboutGoingConcernConditionsOrEvents
The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash or other current assets, nor does it have an established source of revenues sufficient to cover its operating costs, which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issuance of these financial statements.
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
CY2024Q4 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
GFMH Percentage Of Residual Payments
PercentageOfResidualPayments
0.036 pure
CY2024Q4 GFMH Residual Payments
ResidualPayments
0 usd
GFMH Residual Payments
ResidualPayments
0 usd
CY2023Q4 GFMH Residual Payments
ResidualPayments
0 usd
GFMH Residual Payments
ResidualPayments
0 usd
GFMH Balance Amount Of Residual Payments
BalanceAmountOfResidualPayments
0 usd
CY2024Q4 GFMH No Insider Trading Flag
NoInsiderTradingFlag
true

Files In Submission

Name View Source Status
0001493152-24-049310-index-headers.html Edgar Link pending
0001493152-24-049310-index.html Edgar Link pending
0001493152-24-049310.txt Edgar Link pending
0001493152-24-049310-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gfmh-20241031.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gfmh-20241031_def.xml Edgar Link unprocessable
gfmh-20241031_cal.xml Edgar Link unprocessable
gfmh-20241031_lab.xml Edgar Link unprocessable
gfmh-20241031_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed